NSC |
Compound |
Enrichment |
Correlation |
NSC 753456 |
2-4-[5-(3,5-dimethoxyphenyl)-1H-1-imidazolyl]phenyl-5,6,7-trimethoxy-1,3-benzothiazole |
0.0237269271456697 |
0.27021612 |
NSC 744469 |
3-cyano-3,3-diphenylpropyl 4-(3-[(11aS)-7-methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl]oxypropyl)-1-piperazinecarbodithioate |
0.0291420747327558 |
0.61913905 |
NSC 130279 |
7H-1,2,3-Triazolo[4,5-d]pyrimidin-7-one, 3,4-dihydro-3-.beta.-D-ribofuranosyl- (9CI) |
0.029142074732756 |
0.18679342 |
NSC 132791 |
Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo |
0.029142074732756 |
0.34299717 |
NSC 134723 |
K 31 |
0.029142074732756 |
0.11814599 |
NSC 135962 |
Aracytidine 5'-palmitate |
0.029142074732756 |
0.046226969 |
NSC 175493 |
Iron, carbonyl(.eta.(5)-2,4-cyclopentadien-1-yl)(dimethylcarbamodithioato-S,S')- |
0.029142074732756 |
0.24948416 |
NSC 176328 |
Ellipticine, 6-(3-aminopropyl)-, dihydrochloride |
0.029142074732756 |
0.18361547 |
NSC 21683 |
Null |
0.029142074732756 |
0.12649194 |
NSC 31780 |
3H-Indolium, 2-[3-(1,3-dihydro-1,3,3-trimethyl-2H-indol-2-ylidene)-1-propenyl]-1,3,3-trimethyl-, chloride (9CI) |
0.029142074732756 |
0.040811302 |